Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES
Sports Biz Video Gallery
CNBC's Darren Rovell discusses whether rookie sensation Jeremy Lin can revive the Knicks and, in turn, MSG, with CNBC's ...
CNBC's Darren Rovell has a preview of the parade and insight on what the Giants winning means for New York and New Jerse...
darren rovell's sports index
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Current DateTime: 09:56:57 10 Feb 2012
LinksList Documentid: 23279670
Expiration DateTime: 2/10/2012 9:57:30 PM

SPORTS BIZ SLIDESHOWS

» More

Current DateTime: 09:56:58 10 Feb 2012
LinksList Documentid: 37998722

DARREN ROVELL'S SPORTS INDEX

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

ABOUT SPORTS BIZ

Darren Rovell brings you his unique take on the business of sports: a multi-billion dollar global industry and obsession full of personalities and products. On Sports Biz, Darren will give you his up-to-date take on everything from salaries to endorsement deals to marketing and promotions, trades and tirades – in short, everything that makes sports so exciting.

Sports Biz

Text Size
Oct.31
1:24 PM ET
Friday, 31 Oct 2008

Athletes And The Weapons To Fight The "Superbug"

Posted By:Darren Rovell
Sectors:Health Care | Media
Companies:Cepheid

I’m sure you’ve seen all the stories regarding athletes and staph infections more technically known as MRSA.

Although the information each time has been sketchy, the names Kellen Winslow, Tom Brady and Peyton Manning have become associated with it in recent weeks. MRSA is called a “Superbug” because it is resistant to a bevy of antibiotics and therefore can be fatal. That’s created this humungous industry of MRSA combatants.

Cepheid: It’s a publicly traded molecular diagnostics company [CPHD  Loading...      ()   ] that makes a test called the GeneXpert test that detects MRSA. The test supposedly identifies someone who has MRSA within an hour. A usual culture takes as much as three days.

Byotrol: A British company that makes an anti-microbial that combats MRSA and they say works to kill the microorganisms days after it has been applied. Another selling point is that it requires no special protection when applying it.

GagaGen: A biotechnology company that is working on MRSA-resistant products. Received $1.8 million in funding earlier this month for the project.

Himalayan Oregano: A research team is currently investigating the properties of Himalayan oregano oils as an antibacterial agent against MRSA.

Honeymark International: Sells an antiseptic lotion made with manuka honey, one of the only natural substances that has been known to fight off MRSA.

Pure Green: Makes disinfectant and deodorizer that kills MRSA.

Rib-X Pharmaceuticals: Currently developing an antibiotic named Delafloxacin, which kills off a broad spectrum of bacteria including MRSA.

Sana Systems: This company headed by a Los Angeles martial arts school owner makes a new line of products called Athletic Body Care. Says its skin sanitizer, power wash, defense lotion and muscle soak kills 99 percent of germs, including MRSA.

TaiGen Biotechnology: Currently testing a MRSA killing drug called Nemonoxacin.

Tec Laboratories: Makes a product called Staphseptic that it markets to athletic trainers.

More from SportsBiz

Questions?  Comments? 

© 2012 CNBC, Inc. All Rights Reserved



Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 02:33:41 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 11:35:13 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 02:56:30 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters